Overview

Russia/Ukraine Suppression of Ovarian Activity Study

Status:
Completed
Trial end date:
2016-08-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look into the effectiveness of a new investigational medication applied as a transdermal patch. The patch is applied on the skin with study medication that is absorbed through the skin suppressing ovarian activity and therefore preventing an egg from leaving an ovary (ovulation). The study will look into the study drug's safety and how well it is tolerated and its absorption, breakdown and elimination in the body. It describes how the body affects a specific drug after administration.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Contraceptive Agents
Estradiol
Ethinyl Estradiol
Gestodene